Paris-Sana
Today, the World Health Organization approved two drugs to treat people infected with Covid 19, to be added to the group of available means, including vaccines, and others, to stave off the risk of severe symptoms and death from the virus.
In their recommendation, which was published in the British Medical Journal “BMG”, the organization’s experts said, “The arthritis drug baricitinib, used with corticosteroids to treat Covid patients with severe or critical symptoms, improved the survival rate and reduced the need for ventilators.”
Experts also recommended treatment with the synthetic antibody “sutrovimab” for Covid patients who have non-serious symptoms and are at risk of hospitalization, such as the elderly, or those with immunodeficiency or chronic diseases such as diabetes.
So far, three other drugs for Covid-19 patients have been approved by the World Health Organization, starting with corticosteroids for patients with acute symptoms, and low-cost corticosteroids, which are widely used to treat infections that usually accompany acute cases, and the synthetic antibody Regeneron.
The adoption of these drugs comes at a time when hospitals around the world are overwhelmed with patients with the mutated Omicron, while the organization previously expected that half of the European population will be infected with the virus by next March.
Follow Sana's news on Telegram https://t.me/SyrianArabNewsAgency
